Wikidata

(Q61969542)

English

Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)

clinical trial

In more languages

Statements

title
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Refractory Generalized Myasthenia Gravis (gMG) (English)
0 references
country
Argentina
0 references
Australia
0 references
Belgium
0 references
Brazil
0 references
Canada
0 references
Denmark
0 references
Finland
0 references
France
0 references
Germany
0 references
Greece
0 references
Hungary
0 references
Italy
0 references
Japan
0 references
Netherlands
0 references
Spain
0 references
Sweden
0 references
Turkey
0 references
United Kingdom
0 references
main subject
safety
0 references
start time
December 2013
0 references
end time
February 2016
0 references
number of participants
125
0 references
research site
Vanderbilt University
0 references
McGill University
0 references
Osaka University
0 references
Samsung Medical Center
0 references
Hospital de Bellvitge
0 references
University of Alabama
0 references
Yale University
0 references
Augusta University
0 references
Atrium Health
0 references
Rhode Island Hospital
0 references
University of Toronto
0 references
Chiba University
0 references
Kyushu University
0 references
Toho University
0 references
Yamaguchi University
0 references
Yonsei University
0 references
Korea University
0 references
Maastricht University
0 references
Hacettepe University
0 references
Walton Centre
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61969542&oldid=2091609629"